Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-DP for Post-Cataract Surgery Inflammation and Pain
NCT02089113Phase 3Completed
- Sponsor
- Ocular Therapeutix
- Start
- Apr 2014
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in post-operative ocular inflammation and post-operative ocular pain comparing OTX-DP with Placebo Vehicle (2 arms). Primary endpoints: Number of Participants With an Absence of Anterior Chamber Inflammation at Day 14 and Number of Participants With an Absence of Ocular Pain at Day 8. Started Apr 2014; status: completed.
02
Drugs
dexamethasone
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT02089113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089113.